查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2018569

生命科学产品设计与开发服务市场：按服务类型、技术、应用和最终用户划分－2026-2032年全球预测

Life Science Product Design & Development Service Market by Service Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年生命科学产品设计与开发服务市值为310亿美元，预计2026年将成长至346.3亿美元，复合年增长率为12.21%，到2032年将达到694.5亿美元。

主要市场统计数据
基准年 2025 310亿美元
预计年份：2026年 346.3亿美元
预测年份 2032 694.5亿美元
复合年增长率 (%) 12.21%

建立现代生命科学产品开发和设计的策略框架，其中跨学科整合和监管前瞻性对于专案的成功至关重要。

生命科学产品设计与开发领域正经历持续的变革，其驱动力来自技术进步、不断演进的法规结构以及不断变化的商业性需求。本导言概述了影响分子化合物从最初概念到製剂、製程优化、监管申报和分析检验等各阶段的相互关联的因素，并由此引出后续的关键主题。该领域创新速度之快意味着产品团队必须更早整合跨学科专业知识，并保持灵活的开发路径，以缩短首次人体试验的时间，同时确保产品价值。

识别技术、法规和程式工程的关键变化，这些变化需要製定综合发展策略，同时加速创新。

当今时代以变革性变化为特征，这些变化重新定义了生命科学产品的构思、开发和商业化方式。生物製剂、基因编辑和细胞疗法的进步拓展了治疗的可能性，同时也增加了生产的复杂性，因此需要一种新的製程开发模式。为此，研发机构正在采用平台技术和模组化製程框架，以降低单株抗体和下一代治疗方法的生产变异性并加速规模化生产。这些变化正在推动生产模式从单一产品专用工厂转变为能够处理多种产品类别的灵活生产车间。

本分析探讨了 2025 年关税调整和贸易政策变化将如何重塑整个开发平臺。

2025年关税和贸易措施的实施，为生命科学产品开发领域的供应链设计、筹资策略和外包决策增添了新的变数。由于某些原料和成品组件的进口关税提高，企业正在重新审视其供应商组合，并寻求关键试剂和设备的近岸外包。在许多情况下，企业正在加快对替代供应商的认证，并实现采购来源多元化，以降低对单一供应商的依赖风险，同时在研发高峰期扩大高风险物料的库存缓衝。

我们提供按服务类型、技术、治疗应用和最终用户分類的精确细分信息，以支援差异化的开发和商业化方法。

细分市场分析揭示了服务、技术、适应症和最终用户这四个类别各自需要特定的开发和商业化策略。基于服务类型，咨询、开发、法规和测试服务构成相互关联的支柱。开发活动又细分为製剂开发和製程开发；法规服务的特点在于申请文件的准备和提交管理；测试服务则分为分析测试和生物测试。每个细分市场都需要专业的能力：製剂科学家平衡稳定性和可交付性，製程工程师优化工作流程，法规专家将数据转化为可提交的文件，测试团队则产生证据以支持品质和安全声明。

揭示美洲、欧洲、中东和非洲以及亚太地区影响计画实施和伙伴关係选择的细微区域发展趋势和监管差异。

区域趋势对研发路径、监管回应流程和伙伴关係策略有显着影响。在美洲，成熟的法规结构和紧密的合约研发生产机构（CDMO）网络巩固了其作为转化研究和早期临床开发创新中心的地位。这促进了研发和验证活动之间的快速迭代。因此，该地区的相关人员通常优先考虑快速过渡到临床试验，同时保持严格的分析表征以支持监管申报。

评估强调整合能力、平台投资和监管部门核准的製造地的竞争差异化和伙伴关係模式。

在生命科学产品设计和开发生态系统中，竞争地位取决于企业的能力深度、平台投入和策略伙伴关係关係。主要企业透过整合式服务脱颖而出，这些服务将配方和製程开发与强大的分析和生物测试能力相结合，从而实现无缝衔接并缩短开发週期。同时，一些企业则专注于先进基因治疗载体和细胞治疗生产等细分技术领域，凭藉深厚的技术专长，在这些领域获得高价值的合作机会。

高阶主管应采取具体步骤，将监管前瞻性、供应链韧性、模组化製造和数位化能力融入具有竞争力的发展策略中。

产业领导企业应采取一系列切实可行的措施，以确保在研发、监管和商业化方面保持竞争优势。首先，应将监管和测试的考量纳入早期决策，建立跨职能的把关机制，要求在投入大量资源前製定分析策略并确保符合监管要求。这种方法可以减少后续环节的意外事件，并缩短核准时间。其次，应实现供应商网路多元化，并对区域合作伙伴进行认证，以降低关税和地缘政治风险，同时保持随着专案进展快速扩大生产规模的能力。

本文介绍了一种严谨的混合方法研究途径，该方法结合了专家访谈、二手研究、案例研究和迭代检验，以产生可操作的行业见解。

本分析基于混合研究方法，结合了定性专家访谈、与关键相关人员的对话以及对二手文献的整合，从而提供了一个稳健且可操作的观点。对资深研发科学家、监管专家、生产负责人和商业策略家的访谈揭示了近期产品开发週期中面临的实际挑战和切实可行的解决方案。从这些对话中获得的洞见体现在对供应链和监管风险因素的情境分析和敏感度分析中。

本文总结了在开发具有韧性和快速发展的生命科学产品方面所面临的策略挑战，即如何将科学创新与严格的营运和监管要求相结合。

总之，现代生命科学产品的设计和开发需要全面考虑特定模式的科学要求、生产可行性、监管合作以及供应链的稳健性。成功的企业往往能够及早整合分析测试和生物分析的严谨性，采用灵活的製程开发平台，并将监管策略与开发里程碑保持一致。此外，关税波动和区域差异凸显了建立地域分散的采购和合作伙伴网络的重要性，以确保专案的连续性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：生命科学产品设计与开发服务市场：依服务类型划分

  • 咨询
  • 发展
    • 配方开发
    • 製程开发
  • 监管
    • 准备申请文件
    • 应用程式管理
  • 测试
    • 分析测试
    • 生物分析测试

第九章：生命科学产品设计与开发服务市场：依技术划分

  • 生技药品
    • 单株抗体
    • 重组蛋白
    • 疫苗
  • 细胞疗法
  • 基因治疗
  • 低分子化合物

第十章：生命科学产品设计与开发服务市场：依应用领域划分

  • 循环系统
  • 感染疾病
  • 神经病学
  • 肿瘤学
    • 骨髓恶性肿瘤
    • 固体癌

第十一章：生命科学产品设计与开发服务市场：依最终使用者划分

  • 学术和研究机构
  • 生技公司
  • 合约研究机构
  • 製药公司

第十二章：生命科学产品设计与开发服务市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：生命科学产品设计与开发服务市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：生命科学产品设计与开发服务市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国生命科学产品设计与开发服务市场

第十六章：中国生命科学产品设计与开发服务市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accenture plc
  • Agilent Technologies, Inc.
  • AstraZeneca plc
  • Bain & Company
  • Becton Dickinson and Company
  • Biocon Limited
  • Boston Consulting Group
  • Capgemini
  • Cognizant Technology Solutions
  • Dassault Systemes
  • Deloitte
  • GE HealthCare Technologies Inc
  • GSK plc
  • Illumina Inc
  • IQVIA
  • Johnson & Johnson
  • KPMG
  • LEK Consulting
  • McKinsey & Company
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc
  • PricewaterhouseCoopers LLP
  • Sai Life Sciences Limited
  • Tata Consultancy Services
  • Thermo Fisher Scientific Inc
Product Code: MRR-B9334AD6BF04

The Life Science Product Design & Development Service Market was valued at USD 31.00 billion in 2025 and is projected to grow to USD 34.63 billion in 2026, with a CAGR of 12.21%, reaching USD 69.45 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 31.00 billion
Estimated Year [2026] USD 34.63 billion
Forecast Year [2032] USD 69.45 billion
CAGR (%) 12.21%

Establishing the strategic context for modern life science product development and design where multidisciplinary integration and regulatory foresight determine program success

The life science product design and development landscape is undergoing a period of sustained reinvention, driven by technological advances, evolving regulatory frameworks, and shifting commercial imperatives. This introduction frames the critical themes that follow by outlining the interconnected forces that are reshaping how molecular entities progress from early concept through formulation, process optimization, regulatory submission, and analytical validation. The sector's pace of innovation means product teams must integrate multidisciplinary expertise earlier and maintain adaptive development pathways to preserve value and accelerate time to first-in-human studies.

Fundamentally, organizations face a dual mandate: harness next-generation biologic and cell-based modalities while ensuring manufacturability and regulatory readiness. As a result, development strategies are increasingly modular, enabling teams to pivot between formulation and process priorities without derailing program timelines. Concurrently, the demand for robust analytical and bioanalytical testing has escalated, prompting greater collaboration between testing labs and development partners to validate critical quality attributes and support regulatory dossiers. Taken together, these dynamics require leadership to move beyond siloed planning and toward synchronized development pipelines that embed regulatory and testing considerations from the outset.

In summary, this introduction sets the stage for a deeper analysis of transformative shifts, tariff-driven impacts, segmentation nuances, regional variations, competitive positioning, and practical recommendations for leaders aiming to capture the next wave of opportunity in product design and development.

Identifying the critical technological, regulatory, and process engineering shifts that are accelerating innovation while demanding integrated development strategies

The current period is marked by transformative shifts that are redefining how life science products are conceived, developed, and commercialized. Advances in biologics, gene editing, and cell therapy have expanded therapeutic possibilities, but they have also introduced manufacturing complexity that demands new process development paradigms. Consequently, development organizations are adopting platform technologies and modular process frameworks to reduce variability and accelerate scale-up for both monoclonal antibodies and next-generation modalities. These changes are prompting a move away from bespoke, single-product factories toward flexible manufacturing suites that can accommodate multiple product classes.

Moreover, regulatory agencies are evolving their expectations, presenting both opportunities and constraints. Regulators are increasingly open to adaptive approaches and real-world evidence for certain pathways, yet they continue to insist on rigorous analytical characterization and control strategies. This duality compels sponsors to invest earlier in analytical method development and to engage with regulators through pre-submission dialogue to de-risk pathways. At the same time, digital tools for data capture, analytics, and quality management are gaining prominence, enabling predictive control strategies and improved traceability across development stages.

Taken together, these shifts are accelerating the integration of technology, regulatory engagement, and process engineering, encouraging stakeholders to adopt end-to-end thinking that aligns scientific innovation with manufacturability and regulatory feasibility.

Analyzing how tariff adjustments and trade policy changes in 2025 are reshaping supply chain strategies, procurement priorities, and outsourcing decisions across development pipelines

The imposition of tariffs and trade measures in 2025 has introduced new variables into supply chain design, procurement strategy, and outsourcing decisions for life science product development. Rising import duties on certain raw materials and finished components have prompted companies to reassess supplier portfolios and to pursue nearshoring for critical reagents and equipment. In many cases, organizations have accelerated qualification of alternative suppliers and diversified sourcing to mitigate single-supplier exposure, while also expanding inventory buffers for high-risk items during peak development phases.

In response, manufacturing and development teams have placed greater emphasis on localizing high-value upstream processes where tariffs materially impact cost and timing. Process development groups have adapted material specifications to accommodate domestically sourced inputs without compromising critical quality attributes. Furthermore, contract service relationships have evolved as sponsors seek partners with geographically diversified footprints and established compliance pathways for cross-border regulatory filings. Strategic collaboration with contract development and manufacturing organizations now includes explicit clauses addressing tariff risk and supply continuity.

Ultimately, the cumulative effect of tariff changes is to elevate supply chain resilience as a core component of product development strategy. Leaders are adapting by embedding tariff sensitivity into procurement, design-of-experiments, and supplier qualification processes to preserve timelines and control development risk.

Delivering nuanced segmentation intelligence across service types, technologies, therapeutic applications, and end users to inform differentiated development and commercialization approaches

Segmentation analysis reveals how distinct service, technology, application, and end-user categories demand tailored development and commercialization approaches. Based on service type, consulting, development, regulatory, and testing services form interconnected pillars where development activity subdivides into formulation development and process development, regulatory services are differentiated by dossier preparation and submission management, and testing offerings split into analytical testing and bioanalytical testing. Each subsegment requires specialized competencies: formulation scientists balance stability and delivery, process engineers scale workflows, regulatory specialists translate data into submission-ready artifacts, and testing teams generate the evidence that underpins quality and safety assertions.

Based on technology, the landscape spans biologics, cell therapy, gene therapy, and small molecules, with biologics further categorized into monoclonal antibodies, recombinant proteins, and vaccines. Development choices vary markedly across these modalities; for example, monoclonal antibodies often prioritize platform-based expression systems and well-established analytical comparability frameworks, whereas gene and cell therapies hinge on vector design, transduction efficiencies, and potency assays that are still maturing.

Based on application, therapeutic focus areas include cardiovascular, infectious disease, neurology, and oncology, with oncology further segmented into hematological malignancies and solid tumors. Application-specific development strategies reflect distinct efficacy and safety endpoints, patient population considerations, and clinical trial designs. Based on end user, activity centers on academic and research institutes, biotechnology companies, contract research organizations, and pharmaceutical companies, each of which operates with different resource constraints, timelines, and regulatory appetites. Collectively, these segment-level distinctions drive how projects are scoped, resourced, and executed.

Unpacking regional development dynamics and regulatory nuances across the Americas, Europe Middle East & Africa, and Asia-Pacific that affect program execution and partnership choices

Regional dynamics exert a profound influence on development pathways, regulatory sequencing, and partnership strategies. In the Americas, innovation hubs remain strong in translational research and early clinical development, supported by mature regulatory frameworks and dense networks of contract development and manufacturing organizations, which encourages rapid iteration between development and validation activities. Consequently, stakeholders in this region often prioritize speed to clinic while maintaining rigorous analytical characterization to support regulatory filings.

In Europe, Middle East & Africa, regulatory landscapes are diverse, prompting sponsors to adopt harmonized strategies that accommodate regional variances in submission requirements and inspection regimes. This region emphasizes alignment with centralized agencies and a growing focus on decentralized clinical trial models that can efficiently recruit across multiple jurisdictions. Local manufacturing capacity and public-private collaborations are increasingly important to secure supply and support vaccine and biologic initiatives.

In the Asia-Pacific region, investment in manufacturing scale-up, modular facilities, and domestic supplier ecosystems is accelerating. Market participants there often combine cost-effective production capabilities with rapid expansion of bioanalytical and analytical testing capacity. As a result, Asia-Pacific has become a focal point for large-scale clinical manufacturing and for partners seeking cost-efficient yet compliant development pathways. Across all regions, cross-border collaboration and regulatory harmonization efforts remain key enablers of global program execution.

Assessing competitive differentiation and partnership models that favor integrated capabilities, platform investments, and regulatory-proven manufacturing footprints

Competitive positioning in the life science product design and development ecosystem is shaped by capability depth, platform investments, and strategic partnerships. Leading organizations differentiate through integrated service offerings that combine formulation and process development with robust analytical and bioanalytical testing capabilities, enabling seamless handoffs and shortened development cycles. Others compete by specializing in niche technologies such as advanced gene therapy vectors or cell therapy manufacturing, where deep technical expertise commands premium collaboration opportunities.

Partnership models are also evolving; strategic alliances with academic institutions and translational centers provide early access to novel therapeutic concepts and enable joint de-risking of preclinical assets. Contract development and manufacturing organizations that demonstrate regulatory maturity and diversified geographic capacity are winning mandates for pivotal manufacturing and commercialization support. Moreover, companies that invest in digital platforms for data integrity, analytics, and electronic submission readiness increasingly attract clients seeking efficiency and traceability across the development lifecycle.

In this environment, investors and corporate development teams are prioritizing partners with proven quality systems, demonstrated track records in complex modality development, and flexible manufacturing footprints that can scale with emerging therapeutic demand. For product teams, vendor selection is becoming as strategic as internal capability development.

Prescriptive steps for executives to integrate regulatory foresight, supply chain resilience, modular manufacturing, and digital capabilities into competitive development strategies

Industry leaders should pursue a set of actionable moves to secure competitive advantage across development, regulatory, and commercialization dimensions. First, embed regulatory and testing considerations into early-stage decision-making by establishing cross-functional gates that require analytical strategy and regulatory alignment before significant resource allocation. This practice reduces downstream surprises and shortens approval timelines. Second, diversify supplier networks and qualify regional partners to mitigate tariff and geopolitical risk while preserving the ability to scale manufacturing quickly when programs advance.

Third, invest in modular and flexible manufacturing platforms that support multiple modalities; such platforms reduce capital cycle times and enable more efficient utilization of assets. Fourth, prioritize digital capabilities that enhance data provenance, enable predictive quality analytics, and streamline regulatory submissions. These investments not only improve operational execution but also strengthen confidence during regulatory interactions. Fifth, foster strategic partnerships with academic centers and specialized technology providers to access emerging science without overextending in-house teams. Finally, develop clear go-to-market strategies tailored to modality and application, ensuring that commercialization planning begins in parallel with late-stage development activities.

Collectively, these recommendations create a resilient, agile development posture that better aligns scientific innovation with regulatory expectations and market realities, enabling organizations to convert scientific promise into clinical and commercial outcomes.

Explaining the rigorous mixed-methods research approach that integrates expert interviews, secondary synthesis, case studies, and iterative validation to produce pragmatic industry insights

This analysis is grounded in a mixed-methods research approach that combines qualitative expert interviews, primary stakeholder engagements, and secondary literature synthesis to produce a robust, actionable perspective. Interviews were conducted with senior development scientists, regulatory specialists, manufacturing leaders, and commercial strategists to surface practical challenges and real-world solutions encountered during recent product development cycles. These conversations informed scenario analyses and sensitivity reviews of supply chain and regulatory risk factors.

In parallel, secondary research reviewed peer-reviewed publications, regulatory guidance documents, and publicly available technical reports to validate technical assertions and to track recent policy shifts. Triangulation across data sources ensured that insights are corroborated and relevant across multiple contexts. Further, case study analysis of recent modality-specific development programs provided concrete examples of how formulation, process development, and testing strategies were executed and optimized.

Finally, findings were iteratively validated through workshops with seasoned industry leaders to refine recommendations and to ensure that proposed actions are pragmatic and implementable. This methodology balances depth of technical inquiry with practical applicability for decision-makers looking to translate insight into operational action.

Summarizing the strategic imperatives for resilient and responsive life science product development that marry scientific innovation with operational and regulatory rigor

In conclusion, contemporary life science product design and development requires coordinated attention to modality-specific scientific requirements, manufacturing feasibility, regulatory engagement, and supply chain robustness. Organizations that succeed will be those that integrate analytical testing and bioanalytical rigor early, adopt flexible process development platforms, and align regulatory strategy with development milestones. Moreover, tariff-driven shifts and regional variability underscore the need for geographically diversified sourcing and partner networks that can sustain program continuity.

Leaders should view these dynamics as an opportunity to rearchitect development pipelines for resilience and responsiveness. By combining modular manufacturing investments, enhanced digital traceability, and strategic partnerships, teams can shorten development cycles while preserving quality and regulatory compliance. The cumulative insights presented here aim to equip executives with the contextual understanding required to prioritize investments, select partners strategically, and design programs that are both scientifically ambitious and operationally sound.

The path forward is iterative: continuous learning, early regulatory engagement, and disciplined execution will remain the most reliable levers for turning scientific innovation into patient-impacting products.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Life Science Product Design & Development Service Market, by Service Type

  • 8.1. Consulting
  • 8.2. Development
    • 8.2.1. Formulation Development
    • 8.2.2. Process Development
  • 8.3. Regulatory
    • 8.3.1. Dossier Preparation
    • 8.3.2. Submission Management
  • 8.4. Testing
    • 8.4.1. Analytical Testing
    • 8.4.2. Bioanalytical Testing

9. Life Science Product Design & Development Service Market, by Technology

  • 9.1. Biologics
    • 9.1.1. Monoclonal Antibodies
    • 9.1.2. Recombinant Proteins
    • 9.1.3. Vaccines
  • 9.2. Cell Therapy
  • 9.3. Gene Therapy
  • 9.4. Small Molecule

10. Life Science Product Design & Development Service Market, by Application

  • 10.1. Cardiovascular
  • 10.2. Infectious Disease
  • 10.3. Neurology
  • 10.4. Oncology
    • 10.4.1. Hematological Malignancies
    • 10.4.2. Solid Tumors

11. Life Science Product Design & Development Service Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Biotechnology Companies
  • 11.3. Contract Research Organizations
  • 11.4. Pharmaceutical Companies

12. Life Science Product Design & Development Service Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Life Science Product Design & Development Service Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Life Science Product Design & Development Service Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Life Science Product Design & Development Service Market

16. China Life Science Product Design & Development Service Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Accenture plc
  • 17.6. Agilent Technologies, Inc.
  • 17.7. AstraZeneca plc
  • 17.8. Bain & Company
  • 17.9. Becton Dickinson and Company
  • 17.10. Biocon Limited
  • 17.11. Boston Consulting Group
  • 17.12. Capgemini
  • 17.13. Cognizant Technology Solutions
  • 17.14. Dassault Systemes
  • 17.15. Deloitte
  • 17.16. GE HealthCare Technologies Inc
  • 17.17. GSK plc
  • 17.18. Illumina Inc
  • 17.19. IQVIA
  • 17.20. Johnson & Johnson
  • 17.21. KPMG
  • 17.22. L.E.K. Consulting
  • 17.23. McKinsey & Company
  • 17.24. Merck KGaA
  • 17.25. Novartis AG
  • 17.26. Pfizer Inc
  • 17.27. PricewaterhouseCoopers LLP
  • 17.28. Sai Life Sciences Limited
  • 17.29. Tata Consultancy Services
  • 17.30. Thermo Fisher Scientific Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY FORMULATION DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DOSSIER PREPARATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DOSSIER PREPARATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DOSSIER PREPARATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SUBMISSION MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SUBMISSION MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SUBMISSION MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ANALYTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ANALYTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOANALYTICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOANALYTICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 189. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 191. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. GCC LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 218. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 219. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 220. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. G7 LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 227. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 229. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 231. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. NATO LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TESTING, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA LIFE SCIENCE PRODUCT DESIGN & DEVELOPMENT SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)